|
Index of reports
> Cases with Haemoglobin Decreased (112)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Rebetol (Ribavirin) where reactions include haemoglobin decreased. The selected reports were submitted to the FDA during the sample period of about a year. Reports 1 - 30 of 112 Next >>
Possible Rebetol side effects in
Reported by a consumer/non-health professional from Japan on 2012-08-27
Patient:
Reactions: Drug Eruption, Haemoglobin Decreased, Malaise, Hyperglycaemia, Decreased Appetite
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
PEG-Intron
Dosage: 1.5 microgram per kilogram, qw
Indication: Hepatitis C
Start date: 2012-05-17
Rebetol
Dosage: 600 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-05-17
End date: 2012-06-13
Rebetol
Dosage: 400 mg, qd
Administration route: Oral
Rebetol
Dosage: 400 mg, qd
Administration route: Oral
Start date: 2012-06-14
End date: 2012-06-28
Telavic
Dosage: 1500 mg, qd
Administration route: Oral
Start date: 2012-07-18
End date: 2012-07-26
Telavic
Dosage: 2250 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-05-17
End date: 2012-05-25
Telavic
Dosage: 2250 mg, qd
Administration route: Oral
Other drugs received by patient: Motilium; Gasmotin; Diflorasone Diacetate; Nizatidine
Possible Rebetol side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-27
Patient:
Reactions: White Blood Cell Count Decreased, Contusion, Anaemia, Fall, Loss of Consciousness, Haemoglobin Decreased, Anxiety, Dysgeusia, Urine Uric Acid Increased, Disturbance in Attention, Injury, Feeling Abnormal, Asthenia
Drug(s) suspected as cause:
PEG-Intron
Dosage: unk unk, unknown
Indication: Hepatitis C
Start date: 2012-03-03
Rebetol
Dosage: unk unk, qam
Indication: Hepatitis C
Start date: 2012-03-03
Rebetol
Dosage: unk unk, qpm
Rebetol
Dosage: unk unk, qam
Rebetol
Dosage: unk unk, qpm
Start date: 2012-03-03
Rebetol
Dosage: unk unk, qpm
Rebetol
Dosage: unk unk, qam
Victrelis
Dosage: unk unk, unknown
Indication: Hepatitis C
Start date: 2012-03-31
Possible Rebetol side effects in
Reported by a consumer/non-health professional from United States on 2012-08-27
Patient:
Reactions: Haemoglobin Decreased, Dysgeusia, Nausea, Chills, Asthenia
Drug(s) suspected as cause:
PEG-Intron
Dosage: 80 microgram, qw
Rebetol
Dosage: unk
Administration route: Oral
Victrelis
Dosage: unk
Administration route: Oral
Other drugs received by patient: Protonix
Possible Rebetol side effects in
Reported by a physician from Japan on 2012-08-24
Patient:
Reactions: Haemoglobin Decreased, Dizziness
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
PEG-Intron
Dosage: 1.5 microgram per kilogram, qw
Indication: Hepatitis C
Start date: 2012-06-11
Rebetol
Dosage: unk
Rebetol
Dosage: 200 mg, unk
Administration route: Oral
Start date: 2012-06-25
End date: 2012-07-16
Rebetol
Dosage: 400 mg, unk
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-06-11
End date: 2012-06-24
Telavic
Dosage: 2250 mg, unk
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-06-11
End date: 2012-06-15
Telavic
Dosage: 1500 mg, unk
Administration route: Oral
Start date: 2012-06-16
End date: 2012-07-02
Telavic
Dosage: 1000 unk, unk
Administration route: Oral
Start date: 2012-07-03
End date: 2012-07-09
Other drugs received by patient: Valsartan and Hydrochlorothiazide
Possible Rebetol side effects in
Reported by a physician from Japan on 2012-08-24
Patient:
Reactions: Haemoglobin Decreased, Platelet Count Decreased
Drug(s) suspected as cause:
PEG-Intron
Dosage: 1.3 microgram per kilogram, qw
Start date: 2012-06-01
PEG-Intron
Dosage: 1.7 microgram per kilogram, qw
Indication: Hepatitis C
Start date: 2012-04-27
End date: 2012-05-25
Rebetol
Dosage: 400 mg, qd
Administration route: Oral
Start date: 2012-06-29
Rebetol
Dosage: 600 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-04-27
End date: 2012-05-17
Rebetol
Dosage: 200 mg, qd
Administration route: Oral
Start date: 2012-06-01
End date: 2012-06-07
Rebetol
Dosage: 200 mg, qd
Administration route: Oral
Start date: 2012-06-22
End date: 2012-06-28
Rebetol
Dosage: 400 mg, qd
Administration route: Oral
Start date: 2012-05-18
End date: 2012-05-31
Telavic
Dosage: 1000 mg, qd
Administration route: Oral
Start date: 2012-06-01
End date: 2012-06-07
Telavic
Dosage: 1500 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-04-27
End date: 2012-05-31
Telavic
Dosage: 1000 mg, qd
Administration route: Oral
Start date: 2012-06-22
End date: 2012-07-18
Possible Rebetol side effects in
Reported by a physician from Japan on 2012-08-24
Patient:
Reactions: Haemoglobin Decreased, Hepatic Function Abnormal, Erythema
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Antiviral (Unspecified)
Dosage: 2250 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-02-07
End date: 2012-04-30
Incivek
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-02-07
End date: 2012-04-30
PEG-Intron
Dosage: 1.2mcg/kg/week
Start date: 2012-03-23
PEG-Intron
Dosage: 1.5mcg/kg/week
Indication: Hepatitis C
Start date: 2012-01-13
End date: 2012-03-22
PEG-Intron
Dosage: 1.5 microgram per kilogram, unk
End date: 2012-05-04
Rebetol
Dosage: 400 mg, qd
Administration route: Oral
Start date: 2012-04-20
Rebetol
Dosage: 400 mg, once
Administration route: Oral
Start date: 2012-04-20
End date: 2012-05-11
Rebetol
Dosage: 800 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-01-13
End date: 2012-04-19
Other drugs received by patient: Branute; Allegra; Selbex; Loxoprofen; Posterisan; Posterisan; Heparinoid; Flurbiprofen; Branute; Hirudoid; Livostin; Flurbiprofen; Livostin; Allegra
Possible Rebetol side effects in
Reported by a physician from Japan on 2012-08-24
Patient:
Reactions: Haemoglobin Decreased, Renal Impairment, Pericardial Effusion
Drug(s) suspected as cause:
Antiviral (Unspecified)
Dosage: 1000 mg, qd
Administration route: Oral
Start date: 2012-03-09
Antiviral (Unspecified)
Dosage: 1500 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-01-20
End date: 2012-03-08
PEG-Intron
Dosage: 1.5mcg/kg/week
Start date: 2012-01-20
End date: 2012-07-06
PEG-Intron
Dosage: 1.5 ?g/kg, qw
Indication: Hepatitis C
Start date: 2012-01-20
Rebetol
Administration route: Oral
Start date: 2012-06-29
End date: 2012-07-06
Rebetol
Dosage: 400 mg, qd
Administration route: Oral
Start date: 2012-02-10
End date: 2012-03-08
Rebetol
Dosage: 600 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-01-20
End date: 2012-02-09
Rebetol
Dosage: 200 mg, qd
Administration route: Oral
Start date: 2012-03-09
End date: 2012-03-15
Rebetol
Dosage: 200mg/every other day
Administration route: Oral
Start date: 2012-03-30
End date: 2012-05-24
Rebetol
Dosage: 200 mg, unknown
Administration route: Oral
Start date: 2012-03-30
Telavic
Administration route: Oral
Start date: 2012-03-09
Telavic
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-01-20
End date: 2012-03-08
Other drugs received by patient: Urso 250; Celebrex; Cerekinon; [therapy Unspecified]; Calcium Chloride (+) Potassium Chloride (+) Sodium Chloride (+) Sodium; Voltaren; Nexium; Heparinoid; Cerekinon; Hirudoid; Nexium; Celecoxib; Heparinoid; Allopurinol; [therapy Unspecified]
Possible Rebetol side effects in
Reported by a physician from Japan on 2012-08-23
Patient:
Reactions: Haemoglobin Decreased, Anaemia, Renal Tubular Necrosis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
PEG-Intron
Dosage: 0.9mcg/kg/week
Start date: 2012-06-21
End date: 2012-06-21
PEG-Intron
Dosage: 1.8mcg/kg/week
Start date: 2012-05-08
End date: 2012-06-20
PEG-Intron
Dosage: 80mcg/week
Indication: Hepatitis C
Start date: 2012-01-17
End date: 2012-02-01
Rebetol
Administration route: Oral
Start date: 2012-01-27
End date: 2012-02-05
Rebetol
Dosage: 200mg/2 day
Administration route: Oral
Start date: 2012-06-13
End date: 2012-06-21
Rebetol
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-01-17
End date: 2012-01-26
Rebetol
Administration route: Oral
Start date: 2012-05-08
End date: 2012-06-12
Telavic
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-01-17
End date: 2012-02-05
Telavic
Administration route: Oral
Start date: 2012-05-08
End date: 2012-06-21
Other drugs received by patient: Urso 250
Possible Rebetol side effects in
Reported by a individual with unspecified qualification from Japan on 2012-08-23
Patient:
Reactions: Haemoglobin Decreased, Interstitial Lung Disease
Drug(s) suspected as cause:
Antiviral (Unspecified)
Dosage: 750 mg, qd
Administration route: Oral
Start date: 2012-03-30
Antiviral (Unspecified)
Dosage: 2250 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-01-11
End date: 2012-03-29
PEG-Intron
Dosage: 1.25mcg/kg/week
Start date: 2012-02-03
PEG-Intron
Dosage: 1.06mcg/kg/week
Start date: 2012-01-26
End date: 2012-05-31
PEG-Intron
Dosage: 1.3mcg/kg/week
Indication: Hepatitis C
Start date: 2012-01-11
End date: 2012-02-24
PEG-Intron
Dosage: once a week
End date: 2012-01-25
Peginterferon Alfa-2B
Dosage: 1.25 ?g/kg, qw
Start date: 2012-02-03
Peginterferon Alfa-2B
Dosage: 1.3 ?g/kg, qw
Peginterferon Alfa-2B
Dosage: 1.56 ?g/kg, qw
Indication: Hepatitis C
Start date: 2012-01-11
Rebetol
Dosage: 400 mg, qd
Administration route: Oral
Start date: 2012-03-02
Rebetol
Dosage: 800 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-01-11
Rebetol
Dosage: 600 mg, qd
Administration route: Oral
Start date: 2012-02-24
End date: 2012-03-01
Rebetol
Administration route: Oral
Start date: 2012-05-18
End date: 2012-05-31
Rebetol
Administration route: Oral
Start date: 2012-03-02
End date: 2012-05-17
Rebetol
Administration route: Oral
Start date: 2012-01-11
End date: 2012-02-23
Telavic
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-01-11
End date: 2012-03-29
Telavic
Administration route: Oral
Start date: 2012-03-30
End date: 2012-04-06
Telavic
Administration route: Oral
Start date: 2012-03-30
Other drugs received by patient: L Cartin; Epadel; Lendormin; Epadel S; Hange-Shashin-TO; Herbs (Unspecified); Urso 250; Lorfenamin; Mucosta; Urso 250; Lyrica
Possible Rebetol side effects in
Reported by a physician from Philippines on 2012-08-23
Patient:
Reactions: Haemoglobin Decreased, Fatigue, RED Blood Cell Count Decreased, Asthenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
PEG-Intron
Dosage: 80 microgram, qw
Start date: 2012-06-28
Rebetol
Dosage: 800 mg, unk
End date: 2012-08-02
Rebetol
Dosage: 400 unk, unk
Start date: 2012-08-02
Possible Rebetol side effects in
Reported by a physician from United States on 2012-08-23
Patient:
Reactions: Haemoglobin Decreased, Neutrophil Count Decreased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
PEG-Intron
Rebetol
Victrelis
Dosage: 800 mg, tid
Administration route: Oral
Indication: Hepatitis C
Possible Rebetol side effects in
Reported by a physician from Japan on 2012-08-23
Patient:
Reactions: Drug Eruption, Haemoglobin Decreased, Malaise, Hyperglycaemia, Decreased Appetite
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
PEG-Intron
Dosage: 1.5mcg/kg/week
Indication: Hepatitis C
Start date: 2012-05-17
Rebetol
Administration route: Oral
Rebetol
Dosage: 600 mg, once
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-05-17
End date: 2012-06-13
Rebetol
Dosage: 400 mg, qd
Administration route: Oral
Start date: 2012-06-14
End date: 2012-06-28
Rebetol
Dosage: 400 mg, qd
Administration route: Oral
Telavic
Dosage: 2250 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-05-17
End date: 2012-05-25
Telavic
Dosage: 1500 mg, once
Administration route: Oral
Start date: 2012-07-18
End date: 2012-07-26
Telavic
Dosage: 2250 mg, qd
Administration route: Oral
Other drugs received by patient: Gasmotin; Nizatidine; Motilium
Possible Rebetol side effects in
Reported by a physician from Japan on 2012-08-23
Patient:
Reactions: Haemoglobin Decreased, Platelet Count Decreased
Drug(s) suspected as cause:
PEG-Intron
Dosage: 1.5 microgram per kilogram, qw
Indication: Hepatitis C
Start date: 2012-05-25
End date: 2012-05-31
PEG-Intron
Dosage: 0.75 microgram per kilogram, qw
Start date: 2012-06-01
Rebetol
Dosage: 600 mg, qd
Administration route: Oral
Start date: 2012-06-22
Rebetol
Dosage: 800 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-05-25
End date: 2012-06-21
Rebetol
Dosage: unk
Telavic
Dosage: 1500 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-05-25
Possible Rebetol side effects in
Reported by a consumer/non-health professional from Japan on 2012-08-23
Patient:
Reactions: Pancreatitis Acute, Haemoglobin Decreased
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Peginterferon Alfa-2B
Dosage: 1.54 microgram per kilogram, qw
Indication: Hepatitis C
Start date: 2012-02-03
Rebetol
Dosage: 800 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-02-03
End date: 2012-02-16
Rebetol
Dosage: 600 mg, qd
Administration route: Oral
Start date: 2012-02-17
End date: 2012-03-08
Rebetol
Dosage: 400 mg, qd
Administration route: Oral
Start date: 2012-03-09
End date: 2012-04-06
Rebetol
Dosage: 200 mg, qd
Administration route: Oral
Start date: 2012-04-07
End date: 2012-04-20
Telavic
Dosage: 2250 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-02-03
End date: 2012-04-20
Other drugs received by patient: Norvasc; Olmesartan Medoxomil
Possible Rebetol side effects in
Reported by a physician from Japan on 2012-08-23
Patient:
Reactions: Haemoglobin Decreased, Bone Marrow Failure, Neutrophil Count Decreased
Drug(s) suspected as cause:
Antiviral (Unspecified)
Dosage: 2250 mg, qd
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2012-05-26
End date: 2012-06-04
PEG-Intron
Indication: Hepatitis C
PEG-Intron
Dosage: 1.5mcg/kg/week
Indication: Product Used FOR Unknown Indication
Start date: 2012-05-26
End date: 2012-06-04
Rebetol
Dosage: 600 mg, qd
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2012-05-26
End date: 2012-06-04
Rebetol
Indication: Hepatitis C
Telavic
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-05-26
End date: 2012-06-04
Other drugs received by patient: Primperan TAB; LAC-B; Evamyl; Allopurinol
Possible Rebetol side effects in
Reported by a physician from Japan on 2012-08-23
Patient:
Reactions: Haemoglobin Decreased, White Blood Cell Count Decreased, Hypothyroidism, Pyrexia, Neutrophil Count Decreased
Drug(s) suspected as cause:
Interferon Beta NOS
Dosage: 6 million iu, tiw
Start date: 2010-11-17
End date: 2011-09-16
Interferon Beta NOS
Dosage: 6 million iu, qd
Indication: Hepatitis C
Start date: 2010-10-18
End date: 2010-11-15
Rebetol
Dosage: 200 mg, bid
Administration route: Oral
Start date: 2010-11-22
End date: 2011-09-16
Rebetol
Dosage: 200mg 400mg in evening in morning
Administration route: Oral
Indication: Hepatitis C
Start date: 2010-10-18
End date: 2010-11-21
Other drugs received by patient: Mucosta; Mucosta; Pegasys
Possible Rebetol side effects in
Reported by a individual with unspecified qualification from Japan on 2012-08-23
Patient:
Reactions: Haemoglobin Decreased, Blood Urea Increased, Blood Uric Acid Increased, Blood Creatinine Increased
Drug(s) suspected as cause:
Antiviral (Unspecified)
Dosage: 1500 mg, qd
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2012-05-18
End date: 2012-05-21
PEG-Intron
Dosage: 0.75mcg/kg/week
Start date: 2012-06-15
End date: 2012-06-15
PEG-Intron
Dosage: 1.5mcg/kg/week
Indication: Hepatitis C
Start date: 2012-05-18
End date: 2012-06-07
PEG-Intron
Dosage: 1.5 ?g/kg, unknown
Indication: Product Used FOR Unknown Indication
Start date: 2012-05-18
PEG-Intron
Dosage: 1.5mcg/kg/week
Start date: 2012-06-19
Rebetol
Administration route: Oral
Start date: 2012-06-15
Rebetol
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-05-18
End date: 2012-06-14
Rebetol
Dosage: 600 mg, qd
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2012-05-18
Telavic
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-05-18
End date: 2012-05-21
Telavic
Administration route: Oral
Start date: 2012-05-26
Possible Rebetol side effects in
Reported by a individual with unspecified qualification from Japan on 2012-08-23
Patient:
Reactions: Haemoglobin Decreased, White Blood Cell Count Decreased, Neutrophil Count Decreased, Hyperuricaemia
Drug(s) suspected as cause:
Peginterferon Alfa-2B
Dosage: 1.5 microgram per kilogram qw
Indication: Hepatitis C
Start date: 2012-02-07
End date: 2012-03-13
Peginterferon Alfa-2B
Dosage: 0.75 microgram per kilogram, qw
Start date: 2012-07-03
End date: 2012-07-10
Peginterferon Alfa-2B
Dosage: 0.43 microgram per kilogram, qw
Start date: 2012-04-10
End date: 2012-04-10
Peginterferon Alfa-2B
Dosage: 0.6 microgram per kilogram, qw
Start date: 2012-04-17
End date: 2012-05-01
Peginterferon Alfa-2B
Dosage: 0.43 microgram per kilogram, qw
Start date: 2012-05-15
End date: 2012-06-26
Peginterferon Alfa-2B
Dosage: 0.75 microgram per kilogram, qw
Start date: 2012-05-08
End date: 2012-05-08
Peginterferon Alfa-2B
Dosage: 0.75 microgram per kilogram, qw
Start date: 2012-04-03
End date: 2012-04-03
Peginterferon Alfa-2B
Dosage: 0.86 microgram per kilogram, qw
Start date: 2012-07-17
Rebetol
Dosage: 800 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-02-07
End date: 2012-03-05
Rebetol
Dosage: 400 mg, qd
Administration route: Oral
Start date: 2012-04-24
End date: 2012-04-30
Rebetol
Dosage: 200 mg, qd
Administration route: Oral
Start date: 2012-04-03
End date: 2012-04-23
Rebetol
Dosage: 400 mg, qd
Administration route: Oral
Start date: 2012-03-13
End date: 2012-03-18
Rebetol
Dosage: 600 mg, qd
Administration route: Oral
Start date: 2012-05-01
End date: 2012-05-07
Rebetol
Dosage: 600 mg, qd
Administration route: Oral
Start date: 2012-03-06
End date: 2012-03-12
Rebetol
Dosage: 800 mg, qd
Administration route: Oral
Start date: 2012-05-08
Telavic
Dosage: 2250 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-02-07
End date: 2012-03-18
Telavic
Dosage: 750 mg, qd
Administration route: Oral
Start date: 2012-04-03
End date: 2012-04-16
Telavic
Dosage: 1000 mg, qd
Administration route: Oral
Start date: 2012-04-17
End date: 2012-05-08
Other drugs received by patient: Urso 250; Amlodipine; Olmesartan Medoxomil; Olmesartan Medoxomil; Nesina; Confatanin; Posterisan Forte; Clobetasol Propionate
Possible Rebetol side effects in
Reported by a physician from Japan on 2012-08-22
Patient:
Reactions: Haemoglobin Decreased, Drug Eruption
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
PEG-Intron
Dosage: 80mcg/week
Indication: Hepatitis C
Start date: 2012-04-09
Rebetol
Dosage: 400 mg, once
Administration route: Oral
Start date: 2012-05-14
End date: 2012-05-20
Rebetol
Dosage: 600 mg, once
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-04-09
End date: 2012-05-13
Rebetol
Administration route: Oral
Start date: 2012-05-21
Telavic
Administration route: Oral
Start date: 2012-06-04
Telavic
Dosage: 2250 mg, once
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-04-09
End date: 2012-05-27
Telavic
Administration route: Oral
Start date: 2012-05-28
End date: 2012-06-03
Other drugs received by patient: Selbex; Loxonin; Zolpidem; Alendronate Sodium; Voltaren; Loxonin; Rabeprazole Sodium; Urso 250
Possible Rebetol side effects in
Reported by a individual with unspecified qualification from Japan on 2012-08-22
Patient:
Reactions: Haemoglobin Decreased, Nausea, Brain Abscess, Blood Uric Acid Increased, Blood Creatinine Increased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Antiviral (Unspecified)
Dosage: 1500 mg, qd
Administration route: Oral
Start date: 2012-02-24
Antiviral (Unspecified)
Dosage: 2250 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-01-16
End date: 2012-02-23
PEG-Intron
Dosage: 80 microgram per kilogram, qw
Indication: Hepatitis C
Start date: 2012-01-16
PEG-Intron
Dosage: 80 mcg/week
Start date: 2012-01-16
End date: 2012-05-07
Rebetol
Dosage: 400 mg, once
Administration route: Oral
Start date: 2012-02-27
End date: 2012-03-08
Rebetol
Dosage: 600 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-01-16
Rebetol
Dosage: 400 mg, once
Administration route: Oral
Start date: 2012-04-16
End date: 2012-04-22
Rebetol
Dosage: 200 mg/2 days
Administration route: Oral
Start date: 2012-03-09
End date: 2012-04-14
Rebetol
Dosage: 600 mg, once
Administration route: Oral
Start date: 2012-01-16
End date: 2012-02-26
Rebetol
Dosage: 400 mg/2 days
Administration route: Oral
Start date: 2012-03-10
End date: 2012-04-15
Rebetol
Dosage: 600 mg, once
Administration route: Oral
Start date: 2012-04-23
End date: 2012-05-13
Telavic
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-01-16
End date: 2012-02-23
Telavic
Dosage: 1500 mg, once
Administration route: Oral
Start date: 2012-02-24
End date: 2012-04-09
Other drugs received by patient: Carvedilol; Allegra; Carvedilol; Allegra; Diovan; Diovan; Naqua; [therapy Unspecified]; Trichlormethiazide
Possible Rebetol side effects in
Reported by a physician from Japan on 2012-08-22
Patient:
Reactions: Haemoglobin Decreased, Anaemia
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
PEG-Intron
Dosage: 1.5mcg/kg/week
Start date: 2012-06-05
End date: 2012-06-25
PEG-Intron
Dosage: 1.5mcg/kg
Indication: Hepatitis C
Start date: 2012-06-05
End date: 2012-07-10
PEG-Intron
Dosage: 50mcg/week
Start date: 2012-06-26
End date: 2012-07-09
Rebetol
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-06-05
End date: 2012-07-10
Telavic
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-06-05
End date: 2012-07-10
Other drugs received by patient: Miglitol; Metformin HCL
Possible Rebetol side effects in
Reported by a physician from Japan on 2012-08-22
Patient:
Reactions: Haemoglobin Decreased, Decreased Appetite
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
PEG-Intron
Dosage: 1.5mcg/kg/week
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-06-04
End date: 2012-06-24
Rebetol
Administration route: Oral
Start date: 2012-06-18
End date: 2012-06-24
Rebetol
Administration route: Oral
Start date: 2012-06-15
End date: 2012-06-17
Rebetol
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-06-04
End date: 2012-06-04
Rebetol
Administration route: Oral
Start date: 2012-06-05
End date: 2012-06-14
Telavic
Administration route: Oral
Start date: 2012-06-18
End date: 2012-06-24
Telavic
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-06-04
End date: 2012-06-15
Telavic
Administration route: Oral
Start date: 2012-06-16
End date: 2012-06-17
Other drugs received by patient: Iron Sucrose; Amlodipine Besylate; Enalapril Maleate; Bisoprolol Fumarate; Plavix; Trichlormethiazide; Aspirin; Basen OD; Perycit; Crestor
Possible Rebetol side effects in
Reported by a physician from Japan on 2012-08-21
Patient:
Reactions: Haemoglobin Decreased, Hepatic Failure
Adverse event resulted in: death
Drug(s) suspected as cause:
PEG-Intron
Dosage: 0.8mcg/kg/week
PEG-Intron
Dosage: 1.0mcg/kg/week
Indication: Hepatitis C
Start date: 2012-02-24
Rebetol
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-02-24
End date: 2012-04-25
Rebetol
Administration route: Oral
Start date: 2012-04-26
Telavic
Administration route: Oral
Start date: 2012-05-14
End date: 2012-06-01
Telavic
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-02-24
End date: 2012-05-13
Possible Rebetol side effects in
Reported by a physician from Japan on 2012-08-20
Patient:
Reactions: Haemoglobin Decreased, Skin Disorder
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
PEG-Intron
Dosage: 70g/kg/week
Start date: 2012-05-16
End date: 2012-05-16
PEG-Intron
Dosage: 1.2g/kg/week
Indication: Hepatitis C
Start date: 2012-05-02
End date: 2012-05-09
PEG-Intron
Dosage: 80g/kg/week
Start date: 2012-05-23
End date: 2012-06-13
Rebetol
Administration route: Oral
Start date: 2012-06-06
End date: 2012-06-15
Rebetol
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-05-02
End date: 2012-05-24
Rebetol
Administration route: Oral
Start date: 2012-05-25
End date: 2012-06-06
Telavic
Administration route: Oral
Start date: 2012-06-06
End date: 2012-06-15
Telavic
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-05-02
End date: 2012-06-06
Other drugs received by patient: Detomefan; Urso 250; Vitamin E; Talion (Bepotastine Besylate); Marzulene-S; Huscode; Glakay; Mentax; Voltaren-XR
Possible Rebetol side effects in
Reported by a physician from Japan on 2012-08-20
Patient:
Reactions: Haemoglobin Decreased, Renal Impairment
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
PEG-Intron
Dosage: 1.8mcg/kg/week
Indication: Hepatitis C
Start date: 2012-03-06
End date: 2012-05-13
PEG-Intron
Dosage: 1.4mcg/kg/week
Start date: 2012-05-14
Rebetol
Administration route: Oral
Start date: 2012-03-19
End date: 2012-04-30
Rebetol
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-03-06
End date: 2012-03-18
Rebetol
Administration route: Oral
Start date: 2012-05-29
Rebetol
Administration route: Oral
Start date: 2012-05-01
End date: 2012-05-28
Telavic
Administration route: Oral
Start date: 2012-04-24
End date: 2012-05-07
Telavic
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-03-06
End date: 2012-04-23
Telavic
Administration route: Oral
Start date: 2012-05-08
End date: 2012-05-08
Other drugs received by patient: Ubiron; Rebamipide; Elieten; Losartan Potassium; Lendem D; Epadel S; Rebamipide; Bisoprolol Fumarate; Promac (Nitrofurantoin)
Possible Rebetol side effects in
Reported by a physician from Japan on 2012-08-20
Patient:
Reactions: Haemoglobin Decreased, Anaemia
Drug(s) suspected as cause:
Depas
Administration route: Oral
Indication: Adverse Event
Start date: 2012-05-08
Dogmatyl
Administration route: Oral
Indication: Adverse Event
Start date: 2012-04-18
End date: 2012-07-10
PEG-Intron
Dosage: 1.63mcg/kg/week
Start date: 2012-04-24
End date: 2012-04-30
PEG-Intron
Dosage: 1.08mcg/kg/week
Start date: 2012-06-12
PEG-Intron
Dosage: 2.0mcg/kg/week
Indication: Hepatitis C
Start date: 2012-04-17
End date: 2012-04-23
PEG-Intron
Dosage: 1.22mcg/kg/week
Start date: 2012-05-01
PEG-Intron
Dosage: 1.3mcg/kg/week
End date: 2012-06-11
Rebetol
Dosage: 200mg/every other day
Administration route: Oral
Start date: 2012-07-03
Rebetol
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-04-17
End date: 2012-05-21
Rebetol
Administration route: Oral
Start date: 2012-05-22
End date: 2012-06-04
Rebetol
Administration route: Oral
Start date: 2012-06-05
End date: 2012-06-11
Telavic
Dosage: 750 mg, once
Administration route: Oral
Start date: 2012-06-05
End date: 2012-06-11
Telavic
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-04-17
End date: 2012-06-04
Telavic
Administration route: Oral
Start date: 2012-06-12
End date: 2012-06-18
Other drugs received by patient: Losartan Potassium and Hydrochlorothiazide
Possible Rebetol side effects in
Reported by a physician from Japan on 2012-08-15
Patient:
Reactions: Haemoglobin Decreased, Heart Rate Decreased, Pyrexia, Blood Pressure Decreased, Renal Failure Acute
Drug(s) suspected as cause:
PEG-Intron
Dosage: 1.5mcg/kg/week
Indication: Hepatitis C
Start date: 2012-04-18
End date: 2012-04-18
Rebetol
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-04-18
End date: 2012-04-20
Telavic
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-04-18
End date: 2012-04-20
Other drugs received by patient: Digoxin; Losartan Potassium and Hydrochlorothiazide; Warfarin Sodium; Bisoprolol Fumarate; Lasix; Coniel; Warfarin Sodium; Bisoprolol Fumarate; Losartan Potassium and Hydrochlorothiazide; Digoxin; Losartan Potassium and Hydrochlorothiazide; Lasix; Coniel
Possible Rebetol side effects in
Reported by a consumer/non-health professional from Japan on 2012-08-14
Patient:
Reactions: Haemoglobin Decreased, Heart Rate Decreased, Pyrexia, Blood Pressure Decreased, Renal Failure Acute
Drug(s) suspected as cause:
Peginterferon Alfa-2B
Dosage: 1.5 ?g/kg, qw
Indication: Hepatitis C
Start date: 2012-04-18
End date: 2012-04-18
Rebetol
Dosage: 800 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-04-18
End date: 2012-04-20
Telavic
Dosage: 2250 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-04-18
End date: 2012-04-20
Other drugs received by patient: Bisoprolol Fumarate; Hydrochlorothiazide (+) Losartan Potassium; Bisoprolol Fumarate; Lasix; Lasix; Digoxin; Hydrochlorothiazide (+) Losartan Potassium; Warfarin Sodium; Digoxin; Coniel; Hydrochlorothiazide (+) Losartan Potassium; Warfarin Sodium; Coniel
Possible Rebetol side effects in
Reported by a physician from Japan on 2012-08-14
Patient:
Reactions: Haemoglobin Decreased, Platelet Count Decreased
Drug(s) suspected as cause:
PEG-Intron
Dosage: 1.2mcg/kg/week
Start date: 2012-06-04
PEG-Intron
Dosage: 1.5mcg/kg/week
Indication: Hepatitis C
Start date: 2012-01-17
End date: 2012-02-20
PEG-Intron
Dosage: 1.3mcg/kg/week
Start date: 2012-02-27
End date: 2012-02-27
PEG-Intron
Dosage: 0.9mcg/kg/week
Start date: 2012-04-09
End date: 2012-05-28
PEG-Intron
Dosage: 0.9mcg/kg/week
Start date: 2012-03-05
End date: 2012-03-05
PEG-Intron
Dosage: 1.3mcg/kg/week
Start date: 2012-03-12
End date: 2012-04-02
Rebetol
Administration route: Oral
Start date: 2012-07-09
Rebetol
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-01-17
End date: 2012-02-19
Rebetol
Administration route: Oral
Start date: 2012-03-05
End date: 2012-04-08
Rebetol
Administration route: Oral
Start date: 2012-04-09
End date: 2012-04-22
Rebetol
Administration route: Oral
Start date: 2012-06-18
End date: 2012-07-08
Rebetol
Administration route: Oral
Start date: 2012-02-20
End date: 2012-03-04
Rebetol
Administration route: Oral
Start date: 2012-04-23
End date: 2012-06-17
Telavic
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-01-17
End date: 2012-04-09
Other drugs received by patient: Famotidine
Possible Rebetol side effects in
Reported by a physician from Japan on 2012-08-14
Patient:
Reactions: Haemoglobin Decreased, Anaemia, Platelet Count Decreased
Drug(s) suspected as cause:
Antiviral (Unspecified)
Dosage: 2250 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-03-09
End date: 2012-04-26
Antiviral (Unspecified)
Dosage: 750 mg, qd
Administration route: Oral
Start date: 2012-04-27
End date: 2012-05-01
Antiviral (Unspecified)
Dosage: 750 mg, qd
Administration route: Oral
Start date: 2012-05-25
PEG-Intron
Dosage: 1.5mcg/kg/week
Indication: Hepatitis C
Start date: 2012-03-09
End date: 2012-04-20
PEG-Intron
Dosage: 0.75mcg/kg/week
Start date: 2012-06-01
PEG-Intron
Dosage: 0.6mcg/kg/week
Start date: 2012-04-27
End date: 2012-04-27
PEG-Intron
Dosage: 0.6mcg/kg/week
Start date: 2012-05-18
End date: 2012-05-25
Rebetol
Dosage: 1000 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-03-09
End date: 2012-04-12
Rebetol
Dosage: 800 mg, qd
Administration route: Oral
Start date: 2012-04-13
End date: 2012-04-26
Telavic
Administration route: Oral
Start date: 2012-05-25
Telavic
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-03-09
End date: 2012-04-26
Telavic
Administration route: Oral
Start date: 2012-04-27
End date: 2012-05-01
Other drugs received by patient: Miya BM; Taipemin; Allopurinol; Allopurinol; Lanizac; Valsartan and Hydrochlorothiazide; Urso 250; Sodium Ferrous Citrate; Ranitidine Hydrochloride; Valsartan and Hydrochlorothiazide; Bezafibrate; Bezafibrate; Allopurinol; Allopurinol
Page 1 Next >>
|
